Qiagen NV는 주당 0.26의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 연간에 지급되며, 마지막 배당금 지급일은 Jul 2, 2025였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.26
Jul 2, 2025
지급 빈도
지급 비율
연간
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Jul 2, 2025
$0.25
Jul 2, 2025
Jul 10, 2025
Jan 30, 2024
$1.3573
Jan 31, 2024
Feb 1, 2024
배당금 차트
QGEN 배당금
QGEN 배당금 성장률(년간 비교)
Follow-Up Questions
Qiagen NV의 현재 배당금과 연간 배당금은 얼마인가요?
Qiagen NV의 배당 성향은 얼마인가요?
QGEN의 배당락일은 언제인가요?
Qiagen NV은 얼마나 자주 배당금을 지급하나요?
360보고서
주요 통계
이전 종가
$51.06
시가
$51.16
일일 범위
$50.71 - $51.59
52주 범위
$37.63 - $57.82
거래량
1.2M
평균 거래량
2.0M
EPS(TTM)
1.84
배당수익률
--
시가총액
$11.0B
QGEN란 무엇인가요?
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,700 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.